搜尋結果
製品概要. ※ご使用にあたっては 電子添文 をご確認ください. 剤形名. メリスロン錠6mgの添付文書、インタビューフォームなどの情報を掲載しています。 エーザイの医療関係者向け情報サイトです。 医療用医薬品を適正にご使用いただくための情報を提供しています。
Brand name. Merislon Tablets 6mg. Eisai Co., Ltd. Word. 日本語. The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy.
2024年3月29日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) and muscle relaxant ®
2023年12月18日 · 本帖最後由 333s 於 18-12-23 18:12 編輯 Merislon 6mg merislon eisai tokyo japan 可以抑制組織胺釋放，減少末端神經的敏感性，故有助於治療眩暈； 尤其是第一代的抗組織胺由於同時有抗膽鹼作用，對於眩暈的治療效果較佳 副作用及處理方式：.
東京都文京区小石川4-6-10. めまい・平衡障害治療剤; 総称名:メリスロン; 一般名:ベタヒスチンメシル酸塩; 販売名:メリスロン錠6mg, メリスロン錠12mg; 製造会社:エーザイ.
2022年11月7日 · Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for muscle relaxant Myonal ® (generic name: eperisone hydrochloride) and vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) in Asia (9 countries/regions*) to a subs...
2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.
藥品簡介. 本品是一個組織胺類似物。. 劑量資訊. 治療梅尼艾氏症，劑量為一天3次，每次8~16mg。. 藥物動力學. 口服後1小時達到最高血中濃度，大部分由肝臟代謝，半衰期為3.5小時。. 可能副作用. 很少有噁心、嘔吐 及發疹等過敏症狀。. 臨床用途.
You can buy Merislon Tablets 12mg(Betahistine Mesilate) by Eisai Co., Ltd. formed registered in Japan at synapse. "synapse" is a database of pharmaceutical products presented by a pharmaceutical wholesaler; Kosei Pharmaceutical Co., Ltd. Search Orphan
JAN Code：4987028253358. Description. This medicine relieves vertigo by increasing blood flow in inner ear.It is usually used in the treatment of vertigo due to Meniere's disease/syndrome. Presentation. 100 tablets. Feature. white tablet (diameter: 6.1 mm, thickness: 2.4 mm) Active Ingredients. Betahistine mesilate.
